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1 | INTRODUCTION
The COVID-19 pandemic has had a profound impact on every aspect
of UK life in 2020. Health care systems have been radically reshaped at
all levels to prepare for and manage coronavirus admissions whilst
simultaneously trying to limit wider infection. As a consequence, cancer
services have experienced major disruptions across every element of
routine pathways; screening programmes have been suspended, treat-
ments halted and face to face consultations severely restricted.1-3 In
addition, many cancer patients have also been advised to socially isolate
at a time of increased psychological distress and need.
In response to the pandemic, The British Psychosocial Oncology
Society (BPOS) reached out to the society membership and wider
community to gain first hand perspectives on the impact of COVID-
19 on psycho-oncology activity. Views were sought from profes-
sionals working across the field from clinical and third sector services
and academic settings. We wanted to build a picture of how services,
teams and individuals are adapting under the strains of the pan-
demic. Importantly, we sought to understand the challenges being
faced as well as the positive responses and opportunities arising
from the crisis.
2 | METHODS
2.1 | Design
A cross-sectional qualitative survey.
2.2 | Materials
The survey was administered via QUALTRICS between May 19, 2020 and
June 2, 2020 (during which time many lockdown measures were in place
across the UK). The survey included brief demographic items and nine
COVID-19 focused questions with free text response boxes (Figure 1).
2.3 | Participants
We aimed to recruit UK based professionals working in the field of
psychosocial oncology including health professionals (from nursing,
allied health, clinical/medical oncology, clinical psychology, psychia-
try), third sector/charity organisations and academia.
2.4 | Procedure
The survey invitation was disseminated via BPOS membership
(N = 114) and wider networks (email and social media platforms).On behalf of the British Psychosocial Oncology Society Executive Committee
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The information sheet included details on data anonymity and
procedures for stopping participation or withdrawing data.
Participants gave informed consent before continuing to
survey items.
2.5 | Ethics
Ethical approval was gained from Leeds Beckett University Psychol-
ogy Department ethics committee on 19th May 2020 (REC reference
71 829).
2.6 | Data analysis
Demographic information was analysed descriptively with fre-
quencies and proportional data reported using SPSS Version 26.
Data from the open questions were subject to thematic analy-
sis.4 Data were reviewed by all authors, and notes created about
possible codes. Formal coding of data from each question was
completed by two researchers; any discrepancies were dis-
cussed. Codes were extracted and drawn into sub-themes and
themes. These were organised around strengths, weaknesses,
opportunities and threats (SWOT) framework5 to facilitate inter-
pretation. Strengths and weaknesses focus on exploring events
that have already happened; opportunities and threats look to
the future.
3 | RESULTS
3.1 | Sample and demographics
The survey was completed by 94 participants (see Table 1) based in a
range of settings; clinical, n = 47 (50%), academic, n = 33 (35%), third
sector n = 10 (11%), other n = 4 (4%).
3.2 | Survey findings
Key findings are described separately below for psycho-oncology ser-
vices and research activity. Table 2 provides a summary of results
within the SWOT framework.
3.2.1 | Feedback on psycho-oncology services
Challenges: Weaknesses and threats
In response to the wider context of changes to cancer services
(restrictions in treatment delivery and service reductions), the pan-
demic has forced a change in the delivery of psycho-oncology services
and clinical practices:
Patients have had treatment plans altered, e.g. chemo
or radiotherapy instead of surgery, treatments have
been delayed (particularly surgery), new diagnoses are
reduced significantly in number
Respondents reported a reduction in patients referred to psycho-
oncology services. Where services have not been suspended or
closed, patient contact is largely occurring remotely (telephone/video
calls). This has brought technological challenges in service provision
and concerns around how the quality of communication and support
compares to standard face to face delivery:
All psychological care has moved to either telephone or
video calls which has a particular impact for newly
referred patients as this has led to longer waiting times
and the usual care provided is not effective as normal.
Using telephone/video calls to complete assessments is
particularly difficult as there is no existing relationship so
makes it harder to forma therapeutic alliance
Significant concerns were raised around the ability of staff to effec-
tively deliver the same standard of care via remote methods and what
impact this approach was having:
Key points
• To gain insight on UK professionals' experiences and
views of the impact of the COVID-19 pandemic on psy-
cho-oncology activity, the British Psychosocial Oncology
Society (BPOS) conducted an online survey of members
and UK colleagues
• Qualitative data from 94 respondents were analysed the-
matically. Key themes were summarised using the
strengths, weaknesses, opportunities and threats (SWOT)
framework
• Professionals reported severe disruptions in delivering
clinical and supportive care to people affected by cancer
and associated research activity. There were major con-
cerns that the full impact of the pandemic is yet to be
realised.
• In both care and research settings, the pandemic has also
been an impetus for positive changes in working prac-
tices, technology adoption, reducing process barriers and
fostering collaborations which has to potential to be
sustained.
• To mitigate ongoing challenges, is it vital that cancer
organisations work together to adapt and promote psy-
cho-oncology activity to maximise benefit for patients
and professionals in the longer-term.
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the effective removal of face-face contact from every
interaction will have unmapped and unknown effects -
affect moderation, trust, decision-making, adherence -
may make things better or worse - but I am worried it
will be accepted as equivalent for expediency
Lack of face to face monitoring and social isolation has created anxi-
ety and distress amongst some cancer communities potentially
increasing the need for psychological support:
at time of heightened anxiety and risk of psycho-social
morbidity, there will be less people at all of the levels
needed to provide support, advice and care
In relation to the care of cancer patients with COVID-19,
unique challenges were raised with the psychological burden of
treatment options being withdrawn or restricted. Professionals are
managing significant pressures around the “increased emotional
content of work” created from working remotely, supporting col-
leagues and being “disconnected” in some cases from clinical
teams.
There was clear concern that due to the current prioritisation of
resources and services, psychosocial needs of people affected by can-
cer are currently not being adequately met and that an influx of
patients in need was on the horizon:
I worry that when things return to normal we will have
an avalanche of demand
Fears were expressed that important progress made in psycho-
oncology care had been halted whilst services catch-up with the back-
log and influx of patients:
the focus on safety, capacity and treatment is obvi-
ously primary, but sucks out all the air and everything
on wellbeing, QOL and personalised care won't get
another look for a long time
Positives: Strengths and opportunities
Despite these weaknesses and threats, the pandemic has been an
impetus for change, spring-boarding access to technology, facilitating
the quick establishment of options for remote patient contact:
Multiple choice demographic questions 
1. Where are you located? 
2. What is your job role? 
3. In which setting(s) do you work? 
4. If you work in a clinical setting, is it a COVID-free cancer hub? 
Open text questions 
5. Can you tell us about your experience of any changes to psycho-oncology 
services as a result of COVID-19? (e.g. changes for organisations, changes for 
healthcare professionals, changes for patients, changes for carers).  
6. What are the main issues that concern you about the psycho-social aspects of 
cancer care being provided at the moment?  
7. What are the main psycho-social issues that concern you about the treatment of 
cancer patients who also have COVID-19? 
8. Can you tell us about any changes in your research activities and projects in light 
of COVID-19? (e.g. has your mode of data collection changed, or has your study 
been postponed/stopped, has the research workforce been affected?) 
9. What concerns do you have about your research currently and in the future? (e.g. 
resuming research, extending funding) 
10. Please tell us about any benefits to psycho-oncology services that have come 
from COVID-19 
11. Please tell us about any benefits to psycho-oncology research that have come 
from COVID-19 
12. Which, if any, of these benefits are sustainable over time? 
13. If you have any additional comments, please add them here 
F IGURE 1 Survey questions
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Speed of service change - I do think we will think more
creatively about service delivery and be faster at
implementing this going forward
This rapid shift has created opportunities to develop, improve and
refine remote services enabling increased accessibility for some
patients who are unable to travel (distance, too unwell, anxious):
I think remote working for many patients is helpful.
We can often get referrals for patients who live a
considerable distance from the hospital, therefore
being able to work remotely is a real advantage.
Ability to work remotely will be useful with some
patients, particularly those in palliative care with whom
we traditionally wouldn't have completed home visits
once they were unable to come in to see us.
The change to remote working has resulted in many staff working
from home, presenting an opportunity to be more flexible with work-
ing practices in the future.
Permission by NHS Trust to work from home is wel-
come, especially for cancer counsellors who work part-
time and otherwise spend a disproportionate time
commuting, and cost
The skills and value of psycho-oncology professionals have
received increased recognition (including through the provision of
support for health professionals) allowing for new collaborations
within and between different organisations.
I think with engaging/leading on staff support we have
shown the range of skills psycho-oncology clinicians
have within the hospital
Significant new networks of professional contacts
evolving quickly in joint enterprises; hopefully will be
beneficial in future
3.2.2 | Feedback on psycho-oncology research
activity
Challenges: Weaknesses and threats
At an organisational level, the pandemic has had a major impact on
psycho-oncology research delivery as many studies/trials have been
stopped or suspended and the clinical research workforce has been
directed to prioritise COVID-19 research. Where feasible, research
studies have been adapted to take account of the barriers the pan-
demic has presented, whilst viewed negatively by some, it has also led
to new research questions being explored.
With institutions closing buildings housing non-essential services,
large numbers of staff have quickly moved to working remotely, chang-
ing how they work and engage with colleagues and collaborators:
Team working remotely from home, access to some IT
systems not possible, new challenges in maintaining
morale and motivation and managing stress/expectations
for colleagues juggling work-life-carer responsibilities
Respondents were concerned that once lockdown is eased, some
ongoing studies may not restart, meaning they will not achieve the
TABLE 1 Sample demographics
Location N = 94 (%)
North East 0
North West 17 (18.1)
Yorkshire and the Humber 14 (14.9)
East Midlands 2 (2.1)
West Midlands 1(1.1)
East of England 8 (8.5)
London 18 (19.1)
South East 16 (17.0)
South West 7 (7.4)
Wales 5 (5.3)
Northern Ireland 2 (2.1)
Scotland 4 (4.3)
Job role
Clinical research nurse 0
Allied health professional 6 (6.4)
Nurse 9 (9.6)
Doctor 7 (7.4)
Clinical Psychologist 20 (21.3)
Health Psychologist 2 (2.1)
Counselling Psychologist 1 (1.1)
Psychotherapist 2 (2.1)
Psychiatrist 3 (3.2)
Counsellor 2 (2.1)
Academic researcher 29 (30.9)
Charity/Third sector/Non-profit
representative
2 (2.1)
Other (please state) 11 (11.7)
Setting
Clinical 47 (50.0)
Academic 33 (35.1)
Charity/Third sector/Non-profit 10 (10.6)
Other 4 (4.3)
COVID-free cancer hub
Yes 18 (19.1)
No 36 (38.3)
N/A 38 (40.4)
Not reported 2 (2.1)
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planned sample size. Others questioned the sustainability of delivering
research as new cancer pathways have been implemented that limit direct
access to potential participants and clinical staff. At the same time,
funding calls have been pulled or suspended with the result that both
individuals and research teams are increasingly anxious about what the
future holds:
Many research grant calls have been pulled or post-
poned (particularly from Charities). So it feels that sus-
taining the workforce is challenging moving forward,
staff are very anxious about this
Those employed by academic organisations were concerned about the
potential financial impact of the pandemic on this sector and what this
will mean for job security, particularly those on fixed term contracts:
Universities facing massive financial strain- not cur-
rently clear what the implications will be for jobs and
research resources in coming months/years
Positives: Strengths and opportunities
Respondents described a number of positive ways in which research
activity had been maintained and adapted in response to COVID-19.
At an organisational level, ethical and governance administration had
been responsive with procedures being sped up and streamlined:
Ethics and other governance processes have been able
to move incredibly swiftly
The push to remote working has led to a range of potential
benefits for flexibility and productivity in some cases and
demonstrated that many areas of research activity were able to
continue:
I think there is great trust in the research community
that people can be left to get on with their work and
deliver it effectively and responsibly
And for some, there was potentially “no turning back” now these
practices were becoming mainstream. Successful examples of studies
being effectively adapted to take advantage of online/technologically
supported methods were described:
The tech-saviness of more people so research can be
conducted with a wider spread of participants
In some instances, the pandemic has created an environment
which increases the relevance of certain research areas (eg, remote
patient monitoring) which could facilitate opportunities and future
impact. Respondents also described the formation of new research
questions and collaborations with clinical colleagues which may foster
future research developments. The shift to virtual conferences and
research meetings is creating the potential for wider participation and
engagement across academic communities.
4 | CONCLUSIONS AND KEY MESSAGES
Survey respondents shared important insights on the impact of
COVID-19 on psycho-oncology activity.
We recognise our findings are limited by the sample size and
under-representation from some professional groups. However the
TABLE 2 Summary of participant feedback on current psycho-oncology practice and research within the strengths, weaknesses,
opportunities and threats (SWOT) framework
Strengths Weaknesses Opportunities Threats
Practice/service
delivery
• Wider roll-out of
technology now in place
to support remote patient
services
• Professional resilience
and flexibility
• Transferable skill set of
psycho-oncology
professionals
• Limited evidence base
underpinning changes in
service delivery
(remote care)
• Access to technology
currently not standard
across all services or
patient groups
• Chance to develop and
refine application of
remote services and reach
out to more patients
• New internally and
externally formed
networks and
collaborations
• Clear need for ongoing
patient and staff input
from psycho-oncology
• Psycho-oncology not
prioritised
• Risk of major cuts and
funding in clinically
based and third sector
services
• Potential influx of
future patients with
increased
psychosocial need
• Risk of staff burn out
Research • Professional resilience
and flexibility
• Use of technology and
virtual working becoming
established
• Many paused and halted
studies
• Important research
questions side-lined due
to COVID-19
prioritisation
• Important research
questions raised by
COVID-19 and cancer
• Opportunities to build on
and evaluate new creative
ways of working (research
methods, ethical
procedures and use of
online technology, virtual
meeting and conferences)
• Academic institutions
facing economic
challenges and cut-
backs
• Reduced funding
opportunities from
some key charity and
government sources
• Staff burn-out and
increased pressures
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feedback clearly highlights the key issues that have been faced in pre-
ceding months as well as future concerns and opportunities.
It is apparent that psycho-oncology professionals across the field
have dealt with significant challenges during the pandemic. With the
full magnitude of the impact of COVID-19 yet to be realised in cancer
care, more hurdles are undoubtedly on the horizon. Importantly, the
pandemic has in many instances created a platform on which the skills
and knowledge base of many psycho-oncology specialists have been
showcased. Services, teams and individuals have also adapted crea-
tively and flexibly. Technology has been embraced in many practice
and research contexts and is supporting new ways of working. How-
ever, there is much to learn about how effective and sustainable these
approaches will be in the longer term for both professionals and those
living with a beyond a cancer diagnosis.
A period of reflection is now needed to allow professionals across
all areas to take stock of progress and achievements and consider
how best to face future challenges. There is scope to harness oppor-
tunities to shape psycho-oncology care and for practitioners and
researchers to work together productively. It is vital that BPOS and
other cancer focussed professional organisations and societies within
the UK and globally work collaboratively to maintain the profile of
psycho-oncology, mitigate challenges and make the most of opportu-
nities for the benefit of patients and those who care for them. A num-
ber of professional organisations in the UK have responded by
generating coronavirus focussed guidance and information.6-10 With
the response to COVID-19 constantly evolving, further studies are
warranted to understand the practical value of these guidance mate-
rials and determine the longer-term impact of the pandemic on
psycho-oncology in the coming months and years.
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